Here are six takeaways:
1. The Long SpineSTAR is designed to offer surgeons greater access and precision when targeting metastatic spine tumors.
2. The device is part of the DFine’s STAR Tumor Ablation System, and is longer in length with a redesigned electrode knob.
3. Used in a Targeted-Radiofrequency Ablation procedure, the system uses radiofrequency or thermal health to ablate the tumor.
4. An outpatient procedure, Targeted-Radiofrequency Ablation has allowed more than 50 percent of clinical study patients to decrease their pain medications.
5. The SpineSTAR is the only steerable and navigational radiofrequency device on the market.
6. Since the STAR System was released in the United States in 2012, surgeons have performed the surgery on more than 4,000 patients globally.
“The t-RFA procedure is compatible with traditional cancer therapy, often allowing patients to continue chemotherapy and/or radiation therapy with less discomfort,” said Jack Jennings, MD, associate professor in radiology, director of musculoskeletal and spine intervention, Washington University School of Medicine in St. Louis. “The Long SpineSTAR’s increased length will allow us to access and treat a broader spectrum of vertebrae and patients.”
More articles on devices:
Grab some rays — Active individuals may need to maintain higher vitamin D levels to minimize stress fracture risk
Houston Methodis Hospital implements CT-free robotic surgery — 5 key points
OrthoSensor raises $3.9M in funding: 5 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
